CIDD 0067106
CIDD 0067106 is a novel natural product-based diaryloxazole that potent and selective antiproliferative activities against androgen receptor-positive breast cancer cells.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
483.99
Molecular Formula
C26H30ClN3O4
Notes
Research use only, not for human use.
Receptor
MTOR
CAS Number
2151865-39-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1211633-01 0.02 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv1734c/MT1774.1 (Rv1734c, MT1774.1)
Ask
View Details 
MBS1211633-02 0.1 mg (E-Coli)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv1734c/MT1774.1 (Rv1734c, MT1774.1)
Ask
View Details MBS1211633-03 0.02 mg (Yeast)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv1734c/MT1774.1 (Rv1734c, MT1774.1)
Ask
View Details MBS1211633-04 0.1 mg (Yeast)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv1734c/MT1774.1 (Rv1734c, MT1774.1)
Ask
View Details MBS1211633-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium tuberculosis Uncharacterized protein Rv1734c/MT1774.1 (Rv1734c, MT1774.1)
Ask
View Details